Lupin Limited has informed the Exchange regarding a press release dated February 16, 2026, titled "Lupin Signs License and Supply Agreement with Spektus to Commercialize Novel Antidepressant DeslaFlex in Canada".
Press Release Feb 16 2026
Filed with NSE · · 3 pages · English
Release
Earlier from Lupin
- Press Release Feb 13 2026
- Press Release Feb 12 2026
- Press Release Feb 09 2026
- 'Made in India - The story of Desh Bandhu Gupta, Lupin and Indian Pharma' Book Launched in Mumbai
- Press Release Feb 04 2026
Later from Lupin
- Press Release Feb 23 2026
- Lupin Announces the Approval and Launch of Brivaracetam Oral Solution in the United States
- Press Release Feb 24 2026
- Press Release Feb 26 2026
- Press Release (Revised) Feb 26 2026
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin